Deep Genomics Agent
Best for drug discovery
AI-powered genomics
RNA therapy development
Enterprise-grade AI
Deep learning in biology
Programming RNA Therapies Any Gene, Any Genetic condition
Workflow
Drug Discovery
BigRNA
ENTERPRISE
ADVANCED Complexity
CLOUD
Last updated: Apr 15, 2026
deepgenomics.com
Quick Answer
Deep Genomics Agent is an AI platform that revolutionizes drug development by applying advanced AI to RNA biology. It untangles biological complexity, identifies novel therapeutic targets, and evaluates drug candidates for genetic conditions. Best for biopharmaceutical companies and researchers focused on AI-driven genetic medicine. Pricing is enterprise-level.
Decision Intelligence
Best For
Programming RNA therapies for any gene and genetic condition
Accelerating drug discovery through AI-powered prediction
Identifying novel targets in complex genetic diseases
Developing therapeutic candidates for genetic disorders
Biopharmaceutical companies seeking advanced AI in R&D
Not Ideal For
General-purpose AI development or research outside of genomics
Small-scale academic research without significant computational resources
Non-scientific or non-biotech related applications
Users seeking a low-code or no-code AI solution
Fit Score
Complexity
ADVANCED
Company Size
ENTERPRISE
Team Size
LARGE_TEAM
Skill Level
EXPERT
About Deep Genomics Agent
Deep Genomics Agent is an AI platform for drug development that leverages artificial intelligence to untangle the complexity of RNA biology. It identifies novel therapeutic targets and evaluates thousands of possibilities to pinpoint the best therapeutic candidates for genetic conditions. The platform is designed for data-driven prediction and exponential growth in drug discovery.
What Makes Deep Genomics Agent Unique
Deep Genomics developed the first Foundation Model for RNA Biology, BigRNA, and is expanding its capabilities with BigRNA+ to pursue more complex genetic diseases and discover new biology.
Capabilities
Untangling complexity in RNA biology
Identifying novel therapeutic targets
Evaluating thousands of therapeutic candidates
Predicting pathogenic mutations
Developing new therapeutic candidates
Discovering new biology
Data-driven prediction for drug development
RNA splicing defect correction
Task Categories
Pros
- +Leverages AI to address the inherent complexity of RNA biology
- +Proprietary AI Platform designed for data-driven prediction and exponential growth
- +Unlocks novel targets and mechanisms for RNA splicing correction
- +Developed the first Foundation Model for RNA Biology (BigRNA)
- +Capable of expanding into more complex genetic diseases with BigRNA+
Limitations
- -Highly specialized for genetic medicine and RNA biology, not suitable for general AI tasks
- -No public pricing information, likely requiring enterprise-level engagement
- -Requires deep expertise in genomics and AI to fully leverage the platform's outputs
- -No explicit mention of integrations with external R&D tools or systems
Frequently Asked Questions
Your Actions
Dimension Scores
Ease of Use3/10
Output Quality8/10
Value for Money6/10
Customization5/10
Support6/10
Integration1/10
Task Scores
Hypothesis Generation
9
Data Extraction
8
Knowledge Synthesis
8
Literature Search
7
Paper Summarization
7
Cross Reference
7
Methodology Guidance
6
Citation Management
4
Trust Score
35/100
Limited Data
Based on 4 verified signals
Trust Signals
Verified CompanyDeep Genomics
Funding$238M - $241M
Team Size51-200
Data ResidencyCanada and USA
Quick Stats
Agent TypeWorkflow
Memorylong term
Planningadvanced
CategoryDrug Discovery
PlatformsAPI
Views1
Reviews0
LaunchedJan 2023
Status
active
Company & Links